Tackling an Underdiagnosed Disease State

Interview with Jim Cunniff, President and CEO of Electromed (NYSE: ELMD)

Our guest on the show this week was Jim Cunniff, the CEO of Electromed. Electromed is best known for its main product, the SmartVest, a medical device that helps people with a chronic lung condition breathe easier and have a better quality of life. After working at Baxter and Stryker, Jim became CEO in 2023 and has brought a new level of focus and urgency to the Electromed. In this conversation, covered:

·       Why Jim decided to take the CEO role at Electromed;

·       What is special about the SmartVest, as well as the drivers of growth;

·       Why Bronchiectasis remains an underdiagnosed condition;

·       What he has learned from being an operating partner at Shore Capital; and

·       How the company generates 70%+ gross margins.

Please enjoy this fascinating episode here:

Anyone who follows this podcast knows that a common thread throughout the episodes is differentiation. Electromed is essentially a single product company (for now) and I was really curious about how differentiated the SmartVest is in comparison to the other solutions on the market. In this clip, Jim discusses how the product saves the whole system money by keeping patients out of the hospital and the ER.

Thanks to some wonderful introductions from the great followers of the Compounders podcast, we have a packed slate for rest of the year. We hope you will stay tuned for those episodes.

Sincerely,

Ben Claremon